248 related articles for article (PubMed ID: 32250339)
1. Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model.
Hatcher A; Yu K; Meyer J; Aiba I; Deneen B; Noebels JL
J Clin Invest; 2020 May; 130(5):2286-2300. PubMed ID: 32250339
[TBL] [Abstract][Full Text] [Related]
2. Glioma-Derived TSP2 Promotes Excitatory Synapse Formation and Results in Hyperexcitability in the Peritumoral Cortex of Glioma.
Wang YH; Huang TL; Chen X; Yu SX; Li W; Chen T; Li Y; Kuang YQ; Shu HF
J Neuropathol Exp Neurol; 2021 Jan; 80(2):137-149. PubMed ID: 33382873
[TBL] [Abstract][Full Text] [Related]
3. Human glioma cells induce hyperexcitability in cortical networks.
Campbell SL; Buckingham SC; Sontheimer H
Epilepsia; 2012 Aug; 53(8):1360-70. PubMed ID: 22709330
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of NMDA 2B at S1303 in human glioma peritumoral tissue: implications for glioma epileptogenesis.
Gao X; Wang H; Cai S; Saadatzadeh MR; Hanenberg H; Pollok KE; Cohen-Gadol AA; Chen J
Neurosurg Focus; 2014 Dec; 37(6):E17. PubMed ID: 25434386
[TBL] [Abstract][Full Text] [Related]
5. Activation of death-associated protein kinase in human peritumoral tissue: A potential therapeutic target.
Gao X; Wang H; Pollok KE; Chen J; Cohen-Gadol AA
J Clin Neurosci; 2015 Oct; 22(10):1655-60. PubMed ID: 26165472
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma disrupts cortical network activity at multiple spatial and temporal scales.
Meyer J; Yu K; Luna-Figueroa E; Deneen B; Noebels J
Nat Commun; 2024 May; 15(1):4503. PubMed ID: 38802334
[TBL] [Abstract][Full Text] [Related]
7. Activation of the mTOR signaling pathway in peritumoral tissues can cause glioma-associated seizures.
Yuan Y; Xiang W; Yanhui L; Ruofei L; Jiewen L; Shu J; Qing M
Neurol Sci; 2017 Jan; 38(1):61-66. PubMed ID: 27646413
[TBL] [Abstract][Full Text] [Related]
8. Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.
Okolie O; Bago JR; Schmid RS; Irvin DM; Bash RE; Miller CR; Hingtgen SD
Neuro Oncol; 2016 Dec; 18(12):1622-1633. PubMed ID: 27298311
[TBL] [Abstract][Full Text] [Related]
9. Compromised GABAergic inhibition contributes to tumor-associated epilepsy.
MacKenzie G; O'Toole KK; Moss SJ; Maguire J
Epilepsy Res; 2016 Oct; 126():185-96. PubMed ID: 27513374
[TBL] [Abstract][Full Text] [Related]
10. Glioma-induced peritumoral hyperexcitability in a pediatric glioma model.
Chaunsali L; Tewari BP; Gallucci A; Thompson EG; Savoia A; Feld N; Campbell SL
Physiol Rep; 2020 Oct; 8(19):e14567. PubMed ID: 33026196
[TBL] [Abstract][Full Text] [Related]
11. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
12. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.
Lange F; Hörnschemeyer J; Kirschstein T
Cells; 2021 May; 10(5):. PubMed ID: 34067762
[TBL] [Abstract][Full Text] [Related]
13. GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy.
Campbell SL; Robel S; Cuddapah VA; Robert S; Buckingham SC; Kahle KT; Sontheimer H
Glia; 2015 Jan; 63(1):23-36. PubMed ID: 25066727
[TBL] [Abstract][Full Text] [Related]
14. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling.
Zuckermann M; Hovestadt V; Knobbe-Thomsen CB; Zapatka M; Northcott PA; Schramm K; Belic J; Jones DT; Tschida B; Moriarity B; Largaespada D; Roussel MF; Korshunov A; Reifenberger G; Pfister SM; Lichter P; Kawauchi D; Gronych J
Nat Commun; 2015 Jun; 6():7391. PubMed ID: 26067104
[TBL] [Abstract][Full Text] [Related]
15. Potassium and glutamate transport is impaired in scar-forming tumor-associated astrocytes.
Campbell SC; Muñoz-Ballester C; Chaunsali L; Mills WA; Yang JH; Sontheimer H; Robel S
Neurochem Int; 2020 Feb; 133():104628. PubMed ID: 31825815
[TBL] [Abstract][Full Text] [Related]
16. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY
Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.
Leiss L; Mega A; Olsson Bontell T; Nistér M; Smits A; Corvigno S; Rahman MA; Enger PØ; Miletic H; Östman A
Glia; 2020 May; 68(5):979-988. PubMed ID: 31769546
[TBL] [Abstract][Full Text] [Related]
18. Development of a Rat Model for Glioma-Related Epilepsy.
Bouckaert C; Germonpré C; Verhoeven J; Chong SA; Jacquin L; Mairet-Coello G; André VM; Leclercq K; Vanhove C; De Vos F; Van den Broecke C; Goethals I; Descamps B; Donche S; Carrette E; Wadman W; Boon P; Vonck K; Raedt R
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977526
[TBL] [Abstract][Full Text] [Related]
19. A new neurophysiological/neuropathological ex vivo model localizes the origin of glioma-associated epileptogenesis in the invasion area.
Senner V; Köhling R; Püttmann-Cyrus S; Straub H; Paulus W; Speckmann EJ
Acta Neuropathol; 2004 Jan; 107(1):1-7. PubMed ID: 13680280
[TBL] [Abstract][Full Text] [Related]
20. The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.
Magnus N; Meehan B; Garnier D; Hashemi M; Montermini L; Lee TH; Milsom C; Pawlinski R; Ohlfest J; Anderson M; Mackman N; Rak J
Biochem Biophys Res Commun; 2014 Nov; 454(2):262-8. PubMed ID: 25450387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
